Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;7(3):225–239. doi: 10.1016/0168-1702(87)90030-X

Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM

Stephen W Barthold 1,∗, Abigail L Smith 2
PMCID: PMC7134095  PMID: 3037819

Abstract

Mouse hepatitis virus (MHV)-JHM infection was studied in genetically susceptible (BALB/cByJ) and resistant (SJL/J) mice following intranasal inoculation at 1, 3, 6 or 12 wk of age. Markers of infection included histology, immunohistochemistry, virus quantification and virus serology. All BALE mice developed severe disseminated disease with high mortality due to encephalitis and hepatitis. Peak MHV titers appeared in brain, liver, spleen and intestine on days 3 or 5. Age at inoculation did not influence virus titers in brain, spleen or intestine, but virus titers in liver were inversely proportional to age at inoculation. In 6-wk-old BALE mice, virus was cleared from spleen, intestine and liver by day 30 and from brain by day 60. In intestine, MHV was localized to lymphoid tissue, without fecal excretion. SJL mice of all ages developed remarkably milder disease with low mortality occurring only among mice inoculated at 1 wk of age. SJL mice inoculated at 1 wk had disseminated infection at day 3, but lesions and antigen were cleared from most organs by day 5. Mice inoculated at 3 and 6 wk of age had minimal or no involvement of peripheral organs, and mice inoculated at 12 wk of age had infections restricted to the nose. At day 5, MHV titers in brain, liver, spleen and intestine were significantly lower or undetectable in SJL mice of all ages compared to age-matched BALB mice. In 6-wk-old mice, MHV was cleared from all organs by day 10. Serum antibody titers to MHV were many-fold higher in BALB mice, compared to SJL mice, which mounted only a modest response.

Keywords: Mouse hepatitis virus, Corona virus, Mouse

References

  1. Bailey O.T., Pappenheimer A.M., Cheever F.S., Daniels J.B. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: II. Pathology. J. Exp. Med. 1949;90:195–221. doi: 10.1084/jem.90.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bang F.B. Genetics of resistance of animals to viruses: I. Introduction and studies in mice. Adv. Virus Res. 1978;23:269–348. doi: 10.1016/S0065-3527(08)60102-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barthold S.W. Host age and genotypic effects on enterotropic mouse hepatitis virus infection. Lab. Anim. Sci. 1986 in press. [PubMed] [Google Scholar]
  4. Barthold S.W. Research complications and state of knowledge of rodent coronaviruses. In: Hamm T.A., editor. Complications of Viral and Mycoplasmal Infections in Rodents to Toxicological Research and Testing. Hemisphere Publishing Corp; Washington D.C: 1986. pp. 53–89. [Google Scholar]
  5. Barthold S.W., Beck D.S., Smith A.L. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype. Arch. Virol. 1986;91:247–256. doi: 10.1007/BF01314284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barthold S.W., Smith A.L. Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation. Lab. Anim. Sci. 1983;33:355–360. [PubMed] [Google Scholar]
  7. Barthold S.W., Smith A.L. Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Arch. Virol. 1984;81:103–112. doi: 10.1007/BF01309300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Barthold S.W., Smith A.L., Povar M.L. Enterotropic mouse hepatitis virus infection in nude mice. Lab. Anim. Sci. 1985;35:613–618. [PubMed] [Google Scholar]
  9. Carthew P., Sparrow S. Murine coronaviruses: the histopathology of disease induced by intranasal inoculation. Res. Vet. Sci. 1981;30:270–273. doi: 10.1016/S0034-5288(18)32540-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cheever F.S., Daniels J.B., Pappenheimer A.M., Bailey O.T. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: I. Isolation and biological properties of the virus. J. Exp. Med. 1949;90:181–194. doi: 10.1084/jem.90.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ConSmith G., Kalter S.S., Heberling R.L., Helmke R.J. Particles morphologically resembling mouse hepatitis virus in nude mouse uterus. Intervirology. 1976;6:90–97. doi: 10.1159/000149460. [DOI] [PubMed] [Google Scholar]
  12. Gallily R., Warwick A., Bang F.B. Ontogeny of macrophage resistance to mouse hepatitis in vivo and in vitro. J. Exp. Med. 1966;125:537–548. doi: 10.1084/jem.125.4.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goto N., Hirano N., Aiuchi M., Hayashi T., Fujiwara K. Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med. 1977;47:59–70. [PubMed] [Google Scholar]
  14. Haspel M.V., Lampert P.W., Oldstone M.B.A. Vol. 75. 1978. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination; pp. 4033–4036. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Herndon R.M., Griffin D.E., McCormick U., Weiner L.P. Mouse hepatitis virus-induced recurrent demyelination. Arch. Neurol. 1975;32:32–35. doi: 10.1001/archneur.1975.00490430054008. [DOI] [PubMed] [Google Scholar]
  16. Katami K., Taguchi F., Nakayama M., Goto N., Fujiwara K. Vertical transmission of mouse hepatitis virus infection in mice. Jpn. J. Exp. Med. 1978;48:481–490. [PubMed] [Google Scholar]
  17. Knobler R.L., Dubois-Dalcq M., Haspel M.V., Claysmith A.P., Lampert P.W., Oldstone M.B.A. Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J. Neuroimmunol. 1981;1:81–92. doi: 10.1016/0165-5728(81)90010-2. [DOI] [PubMed] [Google Scholar]
  18. Knobler R.L., Haspel M.V., Dubois-Dalcq M., Lampert P.W., Oldstone M.B.A. Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus. Adv. Exp. Biol. Med. 1981;142:341–348. doi: 10.1007/978-1-4757-0456-3_28. [DOI] [PubMed] [Google Scholar]
  19. Knobler R.L., Haspel M.V., Oldstone M.B.A. Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. J. Exp. Med. 1981;153:832–843. doi: 10.1084/jem.153.4.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Knobler R.L., Lampert P.W., Oldstone M.B.A. Virus persistence and recurring demyelination produced by a temperature sensitive mutant of MHV-4. Nature. 1982;298:279–280. doi: 10.1038/298279a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knobler R.L., Tunison L.A., Lampert P.W., Oldstone M.B.A. Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts 8 and ts 15 in BALB/c and SJL mice. Am. J. Pathol. 1982;109:157–168. [PMC free article] [PubMed] [Google Scholar]
  22. Koolen M.J.M., Osterhaus A.D.M.E., van Steenis G., Horzinek M.C., van der Zeijst B.A.M. Temperature-sensitive mutants of mouse hepatitis virus strain A59: isolation, characterization and neuropathogenic properties. Virology. 1983;125:393–402. doi: 10.1016/0042-6822(83)90211-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lavi E., Gilden D.H., Wroblewska Z., Rorke L.B., Weiss S.R. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34:597–603. doi: 10.1212/wnl.34.5.597. [DOI] [PubMed] [Google Scholar]
  24. Lavi E., Gilden D.H., Highkin M.K., Weiss S.R. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 1984;51:563–566. doi: 10.1128/jvi.51.2.563-566.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pickel K., Muller M.A., ter Meulen V. Analysis of age-dependent resistance to murine coronavirus JHM infection in mice. Infect. Immun. 1981;34:648–654. doi: 10.1128/iai.34.3.648-654.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493–497. [Google Scholar]
  27. Robb J.A., Bond C.W., Leibowitz J.L. Pathogenic murine coronaviruses. III. Biological and biochemical characterization of temperature-sensitive mutants of JHMV. Virology. 1979;94:385–399. doi: 10.1016/0042-6822(79)90469-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith A.L., Winograd D.F. Two enzyme immunoassays for the detection of antibody to rodent coronaviruses. J. Virol. Methods. 1986;14:335–343. doi: 10.1016/0166-0934(86)90035-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sorenson O., Percy D., Dales S. In vivo and in vitro models of demyelinating diseases: III. JHM virus infection of rats. Arch. Neurol. 1980;37:478–484. doi: 10.1001/archneur.1980.00500570026003. [DOI] [PubMed] [Google Scholar]
  30. Steel R.G.D., Torrie J.H. McGraw-Hill Book Co; New York: 1960. Principles and Procedures of Statistics. [Google Scholar]
  31. Stohlman S.A., Frelinger J.A. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. I. Genetic analysis. Immunogenetics. 1978;6:277–281. [Google Scholar]
  32. Stohlman S.A., Frelinger J.A., Weiner L.P. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell mediated protection. J. Immunol. 1980;124:1733–1739. [PubMed] [Google Scholar]
  33. Stohlman S.A., Weiner L.P. Chronic central nervous system demyelination in mice after JHM infection. Neurology. 1981;31:38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  34. Stohlman S.A., Woodward J.G., Frelinger J.A. Macrophage antiviral activity: extrinsic versus intrinsic activity. Infect. Immun. 1982;36:672–677. doi: 10.1128/iai.36.2.672-677.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sturman L.S., Takemoto K.K. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect. Immun. 1972;6:501–507. doi: 10.1128/iai.6.4.501-507.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Taguchi F., Aiuchi M., Fujiwara K. Age-dependent response of mice to a mouse hepatitis virus, MHV-S. Jpn. J. Exp. Med. 1977;47:109–115. [PubMed] [Google Scholar]
  37. Taguchi F., Goto Y., Aiuchi M., Hayashi T., Fujiwara K. Pathogenesis of mouse hepatitis virus infection. The role of nasal epithelial cells as a primary target of low-virulence virus, MHV-S. Microbiol. Immunol. 1979;23:249–262. doi: 10.1111/j.1348-0421.1979.tb00461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Taguchi F., Yamada A., Fujiwara K. Factors involved in the age-dependent resistance of mice infected with low virulence mouse hepatitis virus. Arch. Virol. 1979;62:333–340. doi: 10.1007/BF01318107. [DOI] [PubMed] [Google Scholar]
  39. Wege H., Koga M., Watanabe R., Nagashima K., ter Meulen V. Neutrovirulence of murine coronavirus JHM temperature-sensitive mutants in rats. Infect. Immun. 1983;39:1316–1324. doi: 10.1128/iai.39.3.1316-1324.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wege H., Koga M., Wege H., ter Meulen V. JHM infections in rats as a model for acute and subacute demyelinating disease. Adv. Exp. Med. Biol. 1981;142:327–340. doi: 10.1007/978-1-4757-0456-3_27. [DOI] [PubMed] [Google Scholar]
  41. Weiner L. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus) Arch. Neurol. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  42. Woyciechowska J.L., Trapp B.D., Patrick D.H., Shekarchi I.C., Leinikki P.O., Sever J.L., Holmes K.V. Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice. J. Exp. Pathol. 1984;1:295–306. [PubMed] [Google Scholar]

Articles from Virus Research are provided here courtesy of Elsevier

RESOURCES